Every year, our children, parents and loved ones develop critical illnesses like sepsis, ARDS and now COVID-19, which affect millions of people, are linked to the majority of hospital deaths, and have costs in the hundreds of billions (USD). Clinical researchers know that these illnesses are not single diseases but rather heterogeneous syndromes, that new therapies are needed, and that each treatment choice should be personalized. But despite the urgent nature of critical illnesses, advances in new and personalized care still lag behind other areas of medicine.
Endpoint Health is on a mission to solve this problem.
Critical illness leads to:
of U.S. Hospital
Annual Cost to
At Endpoint Health we see these challenges as an opportunity to advance the care of patients with critical illnesses as a whole. We are building the world’s first precision medicine ecosystem focused on critical illness and using it to unlock a deeper understanding of patient biology, to see how this biology impacts treatment response, and to develop promising new targeted therapies as well as validate targeted methods of delivering existing care. Our vision is a world where all key therapies needed for each patient are available and personalized to improve outcomes.
“Our goal is not just to create one test or therapy that can be sold for many uses, rather, it is to ensure that every critical therapy needed for each patient is available and personalized in order to accomplish a single goal – improve outcomes.”